COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention

By Ballinger A.   Smith G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 31-40

Informa Healthcare

Access to resources Recommend Favorite

Clinical Efficacy of Esomeprazole in the Prevention and Healing of Gastrointestinal Toxicity Associated with NSAIDs in Elderly Patients

By Blandizzi Corrado   Tuccori Marco   Colucci Rocchina   Gori Giovanni   Fornai Matteo   Antonioli Luca   Ghisu Narcisa   Mario Del Tacca  

Drugs & Aging, Vol. 25, Iss. 3, 2008-01 ,pp. : 197-208

Adis International

Access to resources Recommend Favorite

Prevention of Cancer in the Upper Gastrointestinal Tract with COX-Inhibition. Still an Option?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 22, 2007-08 ,pp. : 2261-2273

Bentham Science Publishers

Access to resources Recommend Favorite

Gastrointestinal toxicity in elderly osteoarthritis patients treated with NSAIDs

By Palmer Robert H.   DeLapp Ralph  

Inflammopharmacology, Vol. 8, Iss. 1, 2000-03 ,pp. : 19-30

VSP

Access to resources Recommend Favorite

Gastrointestinal side effects of NSAIDs – pharmacoeconomic implications

By MacDonald Thomas M   Sheen Christopher L  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 265-269

Informa Healthcare

Access to resources Recommend Favorite